Lunduyan 2026: DOST-TAPI’s War on the Innovation Gap
The Philippines doesn’t have an invention problem. It has a buyer problem.
That was the uncomfortable premise behind Lunduyan 2026: A Convergence of Stakeholders, Partnerships, and Opportunities, held August 10, 2026, at the Ballroom of Hilton Manila, Newport World Resorts. The Technology Application and Promotion Institute of the Department of Science and Technology (DOST-TAPI) built the day as a transaction hub rather than a ceremony, pulling in institutional lenders, regulators, industry leaders and technology developers to tackle a single bottleneck: local research that never reaches a customer.
Why Filipino Startups Stall Before Market
For most Filipino creators, the hardest part of innovation isn’t the prototype. It’s everything that comes after — commercial capital, intellectual property protection and access to pilot testing, all of it needed before a working device becomes a sustainable enterprise.
The numbers explain the urgency. According to the Philippine Startup Ecosystem Report 2025 by Gobi Partners, local startups contribute an estimated 3 percent to nominal GDP and have created close to 200,000 jobs nationwide. The same report records that total startup funding fell 32 percent year-on-year as global liquidity tightened.
The squeeze is worst in the middle. Foxmont Capital Partners’ 2026 Private Capital Report indicates that deal sizes are beginning to recover, but a funding gap remains for growth-stage ventures. That leaves capital efficiency, transparent governance and rigorous valuation as the terms on which Filipino founders now compete.
In his message of inspiration, DOST Secretary Dr. Renato U. Solidum Jr. pressed the agency’s Agham na Ramdam framework, arguing that local science must leave the university laboratory to solve operational bottlenecks and earn real enterprise revenue. He pointed to Manila HealthTek Inc., the first commercial spin-off of the University of the Philippines Manila, founded by clinical molecular microbiologist Dr. Raul Destura.
That company is the template. Manila HealthTek used DOST-TAPI’s TECHNiCOM program for market testing and its Venture Financing Program for automated manufacturing, and its dengue detection kit — a gold medalist at the 46th International Exhibition of Inventions in Geneva — grew into a diagnostic portfolio now serving dozens of hospitals and laboratories. The company received PHP 70 million in funding from the National Development Company, and DOST-TAPI’s SPICE program carried it into international markets, including London Tech Week 2026.
Inside DOST-TAPI’s New Investment Directory
The agency’s answer to the gap isn’t another grant window. DOST-TAPI announced that it is consolidating a targeted investment directory covering active ventures in public health diagnostics, green technology, agriculture, ICT and renewable energy.
What makes it different is the level of detail. Each entry logs a startup’s current financial standing, funding tier and precise capitalization requirement, giving institutional investors something they can verify independently rather than take on trust. DOST-TAPI Director Atty. Marion Ivy D. Decena, CESO III, framed the shift bluntly in her welcome message: networking alone is insufficient, and the moment calls for data-backed commercialization pathways.
The rest of the program fed the same machine. Sectoral roundtable discussions covering ICT, agriculture, disaster risk reduction and management, water security and renewable energy put industry participants and regulators in front of each other to name market barriers directly. Those inputs are intended to refine DOST-TAPI’s funding mechanisms, PROPEL and PHITEST among them, so they work as pathways instead of paperwork.
A separate focus group discussion on technology commercialization ran alongside, gathering DOST research and development institutes, technology transfer and business development offices, and technology adopters. Deals and recognitions followed, including a partnership signing with OJT Connect on innovation-driven workforce development, and a Certificate of Award for I-TECH Program beneficiary Nature’s Legacy Export, Inc., presented with LANDBANK of the Philippines and received by its President and Chief Executive Officer, Mr. Pedro H. Delantar Jr.
The event also honored BauerTek Farmaceutical Technologies, which took two gold medals in Romania this year for outstanding pharmaceutical innovation and technical excellence. DOST-TAPI closed by presenting its 2027 Call for Proposals, and DOST Undersecretary for Scientific and Technical Services Ms. Maridon O. Sahagun described the day as an actionable blueprint linking current deployment to future enterprise on one investor-ready platform.
